Skip Content
You are currently on the new version of our website. Access the old version .

Hematology Reports, Volume 16, Issue 2

2024 June - 21 articles

Cover Story: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, affecting multiple components of the immune system and causing both peripheral destruction of platelets and impaired central megakaryopoiesis and platelet production in the bone marrow. Here, we intend to contextualize the current knowledge on the pathophysiology, terminology, epidemiology, clinical manifestations, diagnosis, and prognosis of ITP from a historical perspective and the first references to the never-stopping garnering of knowledge about this entity. We highlight the necessity to better understand ITP in order to be able to provide ITP patients with personalized treatment options, improving disease prognosis and reducing the incidence or frequency of refractoriness. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Review
  • Open Access
5 Citations
10,071 Views
15 Pages

Neutropenia in Childhood—A Narrative Review and Practical Diagnostic Approach

  • Georgios Katsaras,
  • Silouani Koutsi,
  • Evdokia Psaroulaki,
  • Dimitra Gouni and
  • Pelagia Tsitsani

Neutropenia refers to a decrease in the absolute neutrophil count according to age and race norms and poses a common concern in pediatric practice. Neutrophils serve as host defenders and act crucially in acute inflammation procedures. In this narrat...

  • Case Report
  • Open Access
2,644 Views
8 Pages

Three-Way Translocation t(12;15;17) (p13;q24;q21) Found in Acute Promyelocytic Leukemia with Basophilic Differentiation

  • Sara Frazzetto,
  • Lara Gullo,
  • Gabriele Sapuppo,
  • Manlio Fazio,
  • Cristina Lo Faro,
  • Giuliana Giunta,
  • Ignazio Caravotta,
  • Elisa Mauro,
  • Marina Silvia Parisi and
  • Francesco Di Raimondo
  • + 7 authors

Acute promyelocytic leukemia is a rare form of acute myeloid leukemia in which immature promyelocytes abnormally proliferate in the bone marrow. In most cases, the disease is characterised by the translocation t(15;17) (q24;q21), which causes the for...

  • Review
  • Open Access
5,710 Views
13 Pages

Skin Hypopigmentation in Hematology Disorders

  • Roberto Mazzetto,
  • Paola Miceli,
  • Alvise Sernicola,
  • Jacopo Tartaglia and
  • Mauro Alaibac

Hypopigmentation disorders pose significant diagnostic challenges in dermatology, sometimes reflecting underlying hematological conditions. This review explores the clinical presentations related to hypopigmentation in hematological disorders, focusi...

  • Case Report
  • Open Access
3,133 Views
7 Pages

Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases

  • Yi-Lun Wang,
  • Tsung-Yen Chang,
  • Yu-Chuan Wen,
  • Shu-Ho Yang,
  • Yi-Wen Hsiao,
  • Chia-Chi Chiu,
  • Yu-Chieh Chen,
  • Ruei-Shan Hu,
  • Shih-Hsiang Chen and
  • Chih-Cheng Hsiao
  • + 1 author

Background/Objectives: Relapsed B-cell acute lymphoblastic leukemia (B-ALL) remains an unresolved matter of concern regarding adverse outcomes. This case study aimed to evaluate the effectiveness of blinatumomab, with or without door lymphocyte infus...

  • Article
  • Open Access
1 Citations
2,501 Views
11 Pages

Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

  • Satoshi Yamasaki,
  • Hiroatsu Iida,
  • Akio Saito,
  • Morio Matsumoto,
  • Yoshiaki Kuroda,
  • Tohru Izumi,
  • Akiko M. Saito,
  • Hiroaki Miyoshi,
  • Koichi Ohshima and
  • Hiromi Iwasaki
  • + 1 author

Romidepsin is an important therapeutic option for patients with peripheral T-cell lymphoma (PTCL). However, the timing of romidepsin administration remains controversial. The objective of this study was to characterize the safety and efficacy of romi...

  • Case Report
  • Open Access
2,522 Views
5 Pages

Morphological Clues of Acute Monocytic Leukemia in COVID-19-Induced Transient Leukoerythroblastic Reaction with Monocytosis

  • Ingrid S. Tam,
  • Mohamed Elemary,
  • John DeCoteau,
  • Anna Porwit and
  • Emina E. Torlakovic

Viral infections, including those caused by COVID-19, can produce striking morphologic changes in peripheral blood. Distinguishing between reactive changes and abnormal morphology of monocytes remains particularly difficult, with low consensus rates...

  • Review
  • Open Access
3 Citations
11,416 Views
14 Pages

Most patients with diffuse large B-cell lymphoma (DLBCL) are >65 years of age, with the number of patients expected to increase in the coming years. A comprehensive geriatric assessment that carefully evaluates fitness status and comorbidities is...

  • Case Report
  • Open Access
2,858 Views
9 Pages

EBV-Positive Nodal T- and NK-Cell Lymphoma Mimicking Anaplastic Large Cell Lymphoma: A Case Report

  • Brooj Abro,
  • Pamela Allen,
  • Saja Asakrah,
  • Kyle Bradley and
  • Linsheng Zhang

EBV-positive nodal T- and NK-cell lymphoma (EBV+ NT/NKCL) is a recently recognized entity in the 5th edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Notably, CD30 positivity is frequently observed in (EBV+ NT/NKCL),...

  • Case Report
  • Open Access
1 Citations
1,992 Views
9 Pages

Complications of Brentuximab Therapy in Patients with Hodgkin’s Lymphoma and Concurrent Autoimmune Pathology—A Case Series

  • Oana Diana Preda,
  • Sorina Bădeliță,
  • Iulia Ursuleac,
  • Ruxandra Maria Irimia,
  • Sonia Balanica,
  • Monica Cojocaru,
  • Cristina Cotruta,
  • Camelia Dobrea and
  • Daniel Coriu

Background: Brentuximab Vedotin (BV) has revolutionized the treatment landscape for Hodgkin’s lymphoma, yet its effects on pre-existing autoimmune disorders remain elusive. Methods: Here, we present four cases of patients with concurrent autoim...

  • Case Report
  • Open Access
3 Citations
2,797 Views
4 Pages

Anti-PF4 ELISA-Negative, SRA-Positive Heparin-Induced Thrombocytopenia

  • Abraham Attah,
  • Chelsea Peterson,
  • Max Jacobs,
  • Rama Bhagavatula,
  • Deep Shah,
  • Robert Kaplan and
  • Yazan Samhouri

Heparin products are frequently used in the inpatient setting to prevent and treat venous thromboembolism, but they simultaneously put patients at risk of developing heparin-induced thrombocytopenia (HIT). The 4Ts score determines the pretest probabi...

  • Article
  • Open Access
1 Citations
2,651 Views
12 Pages

Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study

  • David Michonneau,
  • Raynier Devillier,
  • Mikko Keränen,
  • Marie Thérèse Rubio,
  • Malin Nicklasson,
  • Hélène Labussière-Wallet,
  • Martin Carre,
  • Anne Huynh,
  • Elisabet Viayna and
  • Maija Itälä-Remes
  • + 7 authors

Acute graft-versus-host disease (aGVHD) remains a barrier to successful allogeneic hematopoietic stem cell transplantation (HSCT) outcomes. Contemporary comprehensive analyses of real-world clinical outcomes among patients who develop aGVHD post-HSCT...

  • Review
  • Open Access
8 Citations
3,824 Views
13 Pages

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia

  • Samir Mouhssine,
  • Nawar Maher,
  • Sreekar Kogila,
  • Claudio Cerchione,
  • Giovanni Martinelli and
  • Gianluca Gaidano

30 April 2024

The treatment landscape of chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults, is constantly changing. CLL patients can be divided into three risk categories, based on their IGHV mutational status and the occurrence of TP53 disr...

  • Case Report
  • Open Access
2,293 Views
10 Pages

29 April 2024

Objectives: The aim of this review is to focus on the possibility of patients with squamous cell carcinoma to develop a second primary disease such as DLBCL, perhaps because of the irradiation of the head and neck area. Materials and methods: A case...

  • Case Report
  • Open Access
3,065 Views
5 Pages

Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis

  • Ráhel Réka Bicskó,
  • Árpád Illés,
  • Zsuzsanna Hevessy,
  • Gergely Ivády,
  • György Kerekes,
  • Gábor Méhes,
  • Tünde Csépány and
  • Lajos Gergely

19 April 2024

The co-occurrence of myasthenia gravis (MG) and paroxysmal nocturnal hemoglobinuria (PNH) is rare; only one case has been published so far. We report a 63-year-old Caucasian female patient who was diagnosed with MG at the age of 43. Thymoma was also...

  • Review
  • Open Access
46 Citations
9,042 Views
11 Pages

18 April 2024

Menin inhibitors are new and promising agents currently in clinical development that target the HOX/MEIS1 transcriptional program which is critical for leukemogenesis in histone-lysine N-methyltransferase 2A-rearranged (KMT2Ar) and in NPM1-mutated (N...

  • Communication
  • Open Access
1 Citations
2,365 Views
10 Pages

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience

  • Bianca Serio,
  • Gabriella Storti,
  • Matteo D’Addona,
  • Lidia Santoro,
  • Camilla Frieri,
  • Danilo De Novellis,
  • Luana Marano,
  • Giovanna De Santis,
  • Roberto Guariglia and
  • Carmine Selleri
  • + 10 authors

17 April 2024

Background: Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients, with reported clinical benefits in patients who underwent transplan...

  • Article
  • Open Access
1 Citations
1,843 Views
14 Pages

Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along with a Brief Review of Current Literature

  • John V. Asimakopoulos,
  • Eleni Lalou,
  • George Seferlis,
  • Maria Malliarou,
  • Eliana Konstantinou,
  • Ioannis Drandakis,
  • Ioannis Vasilopoulos,
  • Angeliki N. Georgopoulou,
  • Anastasia Kopsaftopoulou and
  • Maria K. Angelopoulou
  • + 14 authors

16 April 2024

Data on antibody response (AR) after vaccination against SARS-CoV2 in hematopoietic stem-cell transplantation setting (HSCT) were initially scarce, mainly due to the exclusion of such patients from approval studies. Shortly after the worldwide applic...

  • Review
  • Open Access
18 Citations
18,794 Views
16 Pages

Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective

  • Daniel Martínez-Carballeira,
  • Ángel Bernardo,
  • Alberto Caro,
  • Inmaculada Soto and
  • Laura Gutiérrez

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, affecting multiple components of the immune system and causing both per...

  • Review
  • Open Access
3 Citations
3,074 Views
11 Pages

Ophthalmic Manifestations in Patients with Blood Malignancies

  • Costanza Rossi,
  • Alessandro Buizza,
  • Giuseppe Alessio,
  • Massimiliano Borselli,
  • Andrea Taloni,
  • Adriano Carnevali,
  • Giovanna Carnovale Scalzo,
  • Andrea Lucisano,
  • Vincenzo Scorcia and
  • Giuseppe Giannaccare

28 March 2024

Ocular complications can occur in up to 90% of patients with blood malignancies. Such complications range from direct infiltration to local hemostatic imbalance and treatment-related toxicity. This narrative review is based on a systematic computeriz...

  • Case Report
  • Open Access
2,129 Views
8 Pages

Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report

  • Tomofumi Nakamura,
  • Mitsuhiro Uchiba,
  • Hirotomo Nakata,
  • Takao Mizumoto,
  • Toru Beppu and
  • Shuzo Matsushita

26 March 2024

We report a patient with hemophilia A who underwent partial splenic embolization (PSE) for severe thrombocytopenia secondary to portal hypertension-induced splenomegaly, resulting in a stable long-term quality of life. The patient was diagnosed with...

  • Case Report
  • Open Access
3 Citations
2,136 Views
6 Pages

22 March 2024

Background: Indolent T cell lymphoproliferation of the gastrointestinal tract is a novel entity recently added to the 2016 WHO classification of lymphoid neoplasms. Classically, these patients demonstrate an immunophenotype consistent with T cell pro...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hematol. Rep. - ISSN 2038-8330